ENDO INTERNATIONAL PLC (ENDP) Stock Fundamental Analysis

NASDAQ:ENDP • IE00BJ3V9050

0.2926 USD
-0.02 (-5%)
At close: Aug 25, 2022
0.26 USD
-0.03 (-11.14%)
After Hours: 8/25/2022, 10:28:44 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to ENDP. ENDP was compared to 193 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of ENDP have multiple concerns. ENDP has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year ENDP was profitable.
ENDP Yearly Net Income VS EBIT VS OCF VS FCFENDP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 -1B -2B -3B

1.2 Ratios

Industry RankSector Rank
ROA -40.81%
ROE N/A
ROIC 8.07%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ENDP Yearly ROA, ROE, ROICENDP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 200 -200 -400

1.3 Margins

Industry RankSector Rank
OM 19.02%
PM (TTM) -93.31%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ENDP Yearly Profit, Operating, Gross MarginsENDP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ENDP is creating some value.
  • ENDP has more shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, ENDP has a worse debt to assets ratio.
ENDP Yearly Shares OutstandingENDP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M
ENDP Yearly Total Debt VS Total AssetsENDP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 5B 10B

2.2 Solvency

  • Based on the Altman-Z score of -3.02, we must say that ENDP is in the distress zone and has some risk of bankruptcy.
  • A Debt/Equity ratio of -2.52 indicates that ENDP is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity -2.52
Debt/FCF N/A
Altman-Z -3.02
ROIC/WACC1.22
WACC6.62%
ENDP Yearly LT Debt VS Equity VS FCFENDP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 2B 4B 6B 8B

2.3 Liquidity

  • ENDP has a Current Ratio of 1.86. This is a normal value and indicates that ENDP is financially healthy and should not expect problems in meeting its short term obligations.
  • ENDP has a Quick Ratio of 1.62. This is a normal value and indicates that ENDP is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.86
Quick Ratio 1.62
ENDP Yearly Current Assets VS Current LiabilitesENDP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • The earnings per share for ENDP have decreased strongly by -12.08% in the last year.
  • The Earnings Per Share has been decreasing by -8.54% on average over the past years.
  • Looking at the last year, ENDP shows a decrease in Revenue. The Revenue has decreased by -1.56% in the last year.
  • The Revenue has been decreasing by -5.68% on average over the past years.
EPS 1Y (TTM)-12.08%
EPS 3Y1.48%
EPS 5Y-8.54%
EPS Q2Q%-95.38%
Revenue 1Y (TTM)-1.56%
Revenue growth 3Y0.52%
Revenue growth 5Y-5.68%
Sales Q2Q%-20.27%

3.2 Future

  • The Earnings Per Share is expected to decrease by -34.53% on average over the next years. This is quite bad
  • Based on estimates for the next years, ENDP will show a decrease in Revenue. The Revenue will decrease by -8.13% on average per year.
EPS Next Y-57.56%
EPS Next 2Y-45.48%
EPS Next 3Y-38.91%
EPS Next 5Y-34.53%
Revenue Next Year-18.43%
Revenue Next 2Y-12.85%
Revenue Next 3Y-9.64%
Revenue Next 5Y-8.13%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ENDP Yearly Revenue VS EstimatesENDP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B
ENDP Yearly EPS VS EstimatesENDP Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • ENDP is valuated cheaply with a Price/Earnings ratio of 0.13.
  • Compared to an average S&P500 Price/Earnings ratio of 27.13, ENDP is valued rather cheaply.
  • A Price/Forward Earnings ratio of 0.33 indicates a rather cheap valuation of ENDP.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.11, ENDP is valued rather cheaply.
Industry RankSector Rank
PE 0.13
Fwd PE 0.33
ENDP Price Earnings VS Forward Price EarningsENDP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.29
ENDP Per share dataENDP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10

4.3 Compensation for Growth

  • ENDP's earnings are expected to decrease with -38.91% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-45.48%
EPS Next 3Y-38.91%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ENDP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

ENDO INTERNATIONAL PLC

NASDAQ:ENDP (8/25/2022, 10:28:44 PM)

After market: 0.26 -0.03 (-11.14%)

0.2926

-0.02 (-5%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)08-09
Earnings (Next)11-07
Inst Owners0%
Inst Owner Change0%
Ins Owners2.12%
Ins Owner Change0%
Market Cap68.80M
Revenue(TTM)2.78B
Net Income(TTM)-2.60B
Analysts42.86
Price Target1.02 (248.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.13
Fwd PE 0.33
P/S 0.02
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 7.29
EPS(TTM)2.33
EY796.31%
EPS(NY)0.9
Fwd EY306.77%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS11.83
BVpS-13.6
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -40.81%
ROE N/A
ROCE N/A
ROIC 8.07%
ROICexc N/A
ROICexgc 26.18%
OM 19.02%
PM (TTM) -93.31%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity -2.52
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.86
Quick Ratio 1.62
Altman-Z -3.02
F-Score5
WACC6.62%
ROIC/WACC1.22
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.08%
EPS 3Y1.48%
EPS 5Y-8.54%
EPS Q2Q%-95.38%
EPS Next Y-57.56%
EPS Next 2Y-45.48%
EPS Next 3Y-38.91%
EPS Next 5Y-34.53%
Revenue 1Y (TTM)-1.56%
Revenue growth 3Y0.52%
Revenue growth 5Y-5.68%
Sales Q2Q%-20.27%
Revenue Next Year-18.43%
Revenue Next 2Y-12.85%
Revenue Next 3Y-9.64%
Revenue Next 5Y-8.13%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

ENDO INTERNATIONAL PLC / ENDP FAQ

Can you provide the ChartMill fundamental rating for ENDO INTERNATIONAL PLC?

ChartMill assigns a fundamental rating of 2 / 10 to ENDP.


What is the valuation status of ENDO INTERNATIONAL PLC (ENDP) stock?

ChartMill assigns a valuation rating of 6 / 10 to ENDO INTERNATIONAL PLC (ENDP). This can be considered as Fairly Valued.


Can you provide the profitability details for ENDO INTERNATIONAL PLC?

ENDO INTERNATIONAL PLC (ENDP) has a profitability rating of 3 / 10.


What is the valuation of ENDO INTERNATIONAL PLC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ENDO INTERNATIONAL PLC (ENDP) is 0.13 and the Price/Book (PB) ratio is -0.02.


Can you provide the financial health for ENDP stock?

The financial health rating of ENDO INTERNATIONAL PLC (ENDP) is 2 / 10.